health.am

Taking calcium and vitamin D supplements does not reduce the chances of developing breast cancer, according to findings from a U.S. study of women’s health released on Monday, but…

ODC Therapy, Inc., a cancer immunotherapy company started by Baylor Health Care System, announced today that data from an ongoing Phase 2 trial of its dendritic cell vaccine for…

Howard Hughes Medical Institute (HHMI) researchers at Stanford University have found that they can increase bone mass in mice by tweaking the shape of a regulatory protein.

HHMI investigator Gerald Crabtree…

A UCLA/Veteran’s Affairs study showed that more than 40 percent of patients who initially had received a positive result on a fecal occult blood test (FOBT)…

Recent studies suggest that testing blood for prostate specific antigen (PSA) alone does not produce an ideal predictor of prostate cancer, and emerging data suggest this is…

Women who took yoga classes during breast cancer treatment reported they could function better physically and felt better about their health, a small study released on Sunday said.

Sixty-two…

Switching to Pfizer Inc.‘s drug Aromasin after a few years on another breast cancer treatment cut some women’s risk of dying from the disease by 17 percent in a study released…

An experimental drug added to chemotherapy slowed aggressive, late-stage breast cancers that resumed growing despite standard treatment with the drug Herceptin, U.S. researchers said on Saturday.

The drug, Tykerb, by…

A new multicenter study is the first to suggest that the prophylactic removal of the ovaries and fallopian tubes may provide a different benefit for women…

Celgene Inc. said on Sunday its cancer drug Thalomid improved survival by a significant amount in elderly patients with multiple myeloma, a form of blood cancer.

Data presented at the annual…

Amgen Inc. said on Sunday that early results from mid-stage trials of its experimental drug denosumab show that it works at least as well as current therapies to limit…

A Pfizer Inc. kidney cancer drug has also shown promise in a small mid-stage trial as a treatment for the most common form of lung cancer, researchers said on Saturday.

The…

For the first time in decades there are new treatments available for kidney cancer, and as more data emerges about their efficacy, the competition looks set to heat up.

Data presented…

An experimental cervical cancer vaccine made by GlaxoSmithKline Plc produced immune responses in all women ages 15 to 55 in a clinical study, the first evidence that a cervical…

The reason why people are at greater risk of developing cancer as they get older may be explained by research published…

The incidence of breast cancer increases dramatically with age. Given the demographic changes occurring in the United States, the number of elderly women developing breast cancer will continue to rise. Older women as a group have…

Numerous studies have documented that there are significant treatment differences in older patients compared to younger patients. Elderly women with early-stage breast cancer are less likely to undergo breast-conserving surgery than younger women, despite…

A number of studies suggest that older women adjust to breast cancer better than younger women. In a study of 304 women immediately after completion of therapy for…

Metastatic breast cancer is incurable with currently available therapies. Median survival ranges from 2 to 3 years; however, there is substantial variability in survival, with as many as 10% of patients living more than…

Decisions regarding adjuvant therapy should take into account a woman’s risk of disease recurrence, her life expectancy, the benefits and risks of each treatment, and her preferences. Adjuvant tamoxifen clearly reduces the risk of recurrence and…

The role of adjuvant chemotherapy in older women is controversial. Although earlier trials showed minimal benefit in older women, recent larger trials and the Oxford overview analyses have revealed that adjuvant chemotherapy results in modest benefits…

Tamoxifen is an oral synthetic antiestrogen. It is believed to exert its antiestrogenic activity primarily by competitively blocking the binding of estradiol to the estrogen receptor. When estrogen combines with the estrogen receptor in the cell…

Despite advances in local therapy, a substantial proportion of women with early-stage disease will not be cured with local treatment alone. Ten-year disease-free survival rates for patients treated with radical mastectomy alone are shown…

For most older women, treatments offered should be similar to those considered for younger women. However, alternative, less aggressive approaches to local therapy have been sought for older women, particularly for…

Axillary nodal status is the single best predictor of overall survival in women with breast cancer. The presence or absence of lymph node involvement has been an important determinant for the use of…